This is the reply I received from Prof. Facco on the 21st April 2008. I also had a long exchange of opinions with him. Here is his reply:
"Dear colleague, the criticism and discussion on our study is welcome and I'm pleased to answer, providing the information you asked for.
It seems to me that the comments may rise , at least partially, from some skepticism about acupuncture. I do believe that keeping a neutral stance is mandatory in the world of science, since both fideistic and skeptical stances, which have the same nature, may be a source of bias: both of them look like the two facets of the same medal, since they may favor an a priori position, increasing the risk of wrong judgement in a positive (fideistic) or negative (skeptical) way.
From the request, I received, it seems to me that the criticism includes contradictory elements and does not take into account the whole paper, but only focuses on a single aspect of methods. Of course, the item of blinding is essential, but a proper evaluation of the study calls for taking into account other relevant aspects, such as the problems of research in acupuncture (see Ceccherelli and Facco, as a review) and reappraising of the definition of the term "placebo".
Double blinding, as well as a truly inert placebo, can be performed with drug therapy only. Obviously, acupuncture does not allow double blinding, likewise surgery and behavioral therapies, but this is not a fault: one can partially overcome this problem by blinding who is charged for the data analysis (myself, as regards our study).
The aim of our study (for the first time in western literature, to my knoledge) was the attempt to merge Western Medicine and TMC in a whole, to check whether could be feasible studying TMC with the current scientific methods. The reason for such a choice was that too many papers dealing with acupuncture, used needles and acupoints without applying the TMC: it cannot be considered as true acupuncture, since it does ignore the diagnosis and appropriate treatment according to TMC, thus introducing a strong bias in the process of validation (or falsification) of acupuncture.
Understanding the meaning of results, besides checking methods, calls for a good knowledge of the topic: I believe that one may misunderstand the results of a scientific paper on pain and/or acupuncture, when pathophysiology of pain, its modulation in the CNS and the mechanisms of pain relief (both acupuncture and the so-called placebo) are not taken into account. Therefore, I shall provide the information you asked me for together with a few comments on placebo, hoping that they will provide some useful information:
1. The patients were randomized and allocated to each group using sealed envelopes.
2. The aim of the study was to check whether acupuncture according to TMC may be effective: it implied the use of a non scientific paradigm and a variable treatment according to TMC, which is not considered plausible by Western Medicine and, as a consequence, presumed to be meaningless. Since all the patients were administered a western attack treatment, they were not informed about true or mock acupuncture. They were informed that, according to different Chinese syndromes, they might have been submitted to a stronger or milder acupuncture treatment, the latter using a painless technique with superficial puncture (likewise abdominal acupuncture, a new almost painless technique). They were also informed that at the end of the treatment and follow-up (that is after T2), should they have no relief, they would have been submitted to re-evaluation of their migraine and a new treatment would have been administered accordingly, free of charge. In this way, no doubt about the type of applied acupuncture was introduced, while delivering an effective attack treatment to all patients and assuring a proper acupuncture treatment after placebo, if needed. Futhermore, the effects of mock acupuncture might not be easily told from those of Rizatriptan in the overall change of symptoms, contributing to the credibility of placebo. Thus, we do believe that patients were satisfactorilly blinded; futhermore there is no possibility of different credibility of RMA and SMA since they were performed in the same way; the only difference was in the more empathic, systemic approach according to the diagnostic process of TMC in group RMA, and the more standard , Western style of SMA. In our opinion, this was new relevant source of effects to be checked, related to different approach (and related changes of patient's feeling of being cared of and expectation), not to needles or acupoints.
3. We are aware that the study has some limitations, such as the lack of post-hoc analysis about placebo credibility: however, it was not possible since the patients ignored the placebo (the authors did not even know whether the TMC would have behaved better than placebo), but knew about different kinds of treatments according to TMC diagnosis.
4. Our main interest was to provide a preliminary estimate on the possibility of applying the paradigm of TMC, merging it with the scientific method, rather than showing which, if any, would be the best acupuncture treatment of migraine. This is a matter of futher study, which calls for facing the hard problem of fully understanding the Chinese classification and therapy of headache. This has been emphasized in this discussion.
The criticism to our study looks to me rather contradictory (perhaps I may have misunderstood the remarks) for the following reasons:
A. The significant effects of RMA on pain at T1, as a matter of facts, confirms the credibility of the mock acupuncture, despite it can be used by skeptics to claim to patients that TA is not effective.
B. The lack of effects of SMA, can lead skeptics to claim that patients were aware of placebo, but it was very unlikely, since needle applications was performed exactly in the same way as RMA.
C. The only difference between RMA and SMA was in the approach according to TMC, not in needle application: it allowed for checking whether TMC might provide a better feeling of being cared, thus improving patient's expectance and possible placebo effects.
D. The "placebo effect" of RMA was at T1 only (that is, at the end of treatment), but, unlike TA, these effects had dissapeared at the follow-up (T2).
E. The factorial ANOVA (taking into account group differences at any time) allowed to show that there is a specific significant effect of TA at T2: this is indeed specific effect of TA only, unrelated to placebo.
F. The significant effects of RMA at T1 do not allow for concluding that TA was ineffective; rather, they indicate that the overall effects of acupuncture, with its systemic approach, involve both specific, needle related effects, and subjective factors; in other words, acupuncture is much more than needles alone.
G. The conventioal concept of "placebo" may affect the criticism as well. In the discussion, I mentioned the concept of Iatroplacebogenesis: the real therapeutic potential of the so-called placebo is increasingly recognized in the literature of pain and its traditional, obsolete, meaning is no longer enough. The so-called placebo may account for both RMA and , partially, TA effects. Simply subtracting the true from placebo effects may be misleading, when dealing with non-pharmacological treatments, with the risk of taking the baby for the bath water. As fa as the problem of placebo is concerned, it is now time to deeply reappraise its definition, role and effects in order to avoid wrong conclusions.
Reference List:
1. Ceccherelli F. FAcco E: Methodological problems on acupuncture research in pain therapy. Capasso A (Ed.), Kerala, India., Research signpost, 2005, pp 217-28
2. Benedetti F: Placebo analgesia, Neurol. Sci, 2006; Suppl2: S100-S102
3. Diener HC: Placebo in headache trials, Cephalalgia 2003; 23:485-6
4. Kong J, Gollub RL, Rosman IS, Webb JM, Kirsch I, Kaptchuck TJ: Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci. 2006; 26: 381-8
5. PatersonC, Dieppe P: Characteristics and incidental (placebo) effects in complex interventions such as acupuncture. BMJ 2005; 330: 1202-5"